Stoke Therapeutics, Inc. · NASDAQ:STOK

Ticho Barry sold 5,545 Stoke Therapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Ticho Barry (CHIEF MEDICAL OFFICER) sold 5,545 Stoke Therapeutics, Inc. shares at an average US$30.67 for US$170K under a trading plan, leaving 20,110 shares. Filed Sep 3, 2026 (Form 4).

Sold: 5,545 shares
Price: US$30.67 average (US$30.51 to US$31.06)
Value: US$170K
Holding after: 20,110 shares
Trading plan: Yes (Made under a plan set in advance)
Role: CHIEF MEDICAL OFFICER

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 1, 2026	Common Stock	Sale	3,945	US$30.51	21,710	Direct
Sep 1, 2026	Common Stock	Sale	1,600	US$31.06	20,110	Direct

Source

View original at SEC

Related